Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex.

Horner WE, Johnson DE, Schmidt AW, Rollema H.

Eur J Pharmacol. 2007 Mar 8;558(1-3):96-7. Epub 2006 Dec 1.

PMID:
17198700
2.
4.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
5.

New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.

Heal DJ, Smith SL, Kulkarni RS, Rowley HL.

Pharmacol Biochem Behav. 2008 Aug;90(2):184-97. doi: 10.1016/j.pbb.2008.03.016. Epub 2008 Apr 1. Review.

PMID:
18456311
6.

Atomoxetine.

Unni JC.

Indian Pediatr. 2006 Jul;43(7):603-6. Review. No abstract available.

7.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
8.

InforMatrix for attention deficit hyperactivity disorder.

Janknegt R, Faber A, Rodrigues Pereira R, Kalverdijk LJ.

Expert Opin Pharmacother. 2009 Apr;10(5):755-72. doi: 10.1517/14656560902765769 . Review.

PMID:
19351226
9.

Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.

Prince J.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S39-45. doi: 10.1097/JCP.0b013e318174f92a. Review.

PMID:
18480676
10.

Dopamine vs noradrenaline: inverted-U effects and ADHD theories.

Levy F.

Aust N Z J Psychiatry. 2009 Feb;43(2):101-8. doi: 10.1080/00048670802607238. Review.

PMID:
19153917
11.

Update on drugs for hyperactivity in childhood.

[No authors listed]

Drug Ther Bull. 2007 May;45(5):37-40. Review. Erratum in: Drug Ther Bull. 2007 Nov;45(11):88. Drug Ther Bull. 2007 Aug;45(8):64.

PMID:
17536494
12.

Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.

Vaughan BS, Wetzel MW, Kratochvil CJ.

Int Rev Psychiatry. 2008 Apr;20(2):143-9. doi: 10.1080/09540260801887751. Review.

PMID:
18386204
13.

Stimulants: Therapeutic actions in ADHD.

Arnsten AF.

Neuropsychopharmacology. 2006 Nov;31(11):2376-83. Epub 2006 Jul 19. Review.

14.

Catecholamine influences on dorsolateral prefrontal cortical networks.

Arnsten AF.

Biol Psychiatry. 2011 Jun 15;69(12):e89-99. doi: 10.1016/j.biopsych.2011.01.027. Epub 2011 Apr 13. Review.

15.

Clinical review: evidence-based diagnosis and treatment of ADHD in children.

Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A.

Mo Med. 2006 Nov-Dec;103(6):617-21. Review.

PMID:
17256270
16.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
17.

Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder.

Vaughan B, Fegert J, Kratochvil CJ.

Expert Opin Pharmacother. 2009 Mar;10(4):669-76. doi: 10.1517/14656560902762873 . Review.

PMID:
19239401
18.

[My child is so restless].

Schlamp D.

MMW Fortschr Med. 2007 Mar 8;149(10):39-40. Review. German.

PMID:
17408047
19.

Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Arnsten AF, Pliszka SR.

Pharmacol Biochem Behav. 2011 Aug;99(2):211-6. doi: 10.1016/j.pbb.2011.01.020. Epub 2011 Feb 2. Review.

20.

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Arnsten AF, Li BM.

Biol Psychiatry. 2005 Jun 1;57(11):1377-84. Review.

PMID:
15950011

Supplemental Content

Support Center